IFNB1 and myeloid sarcoma: There were no significant differences reported in the complexity characteristics of EEG signals between MS patients undergoing treatment with IFN-β and DMF at the first and second measurements, which rejects the hypothesis that patients treated with DMF will exhibit significant differences in complexity characteristics compared to patients treated with IFN-β.